Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Guy L Weinberg & Malek G Massad. (2007) Metabolic modulation for cardiac protection. Expert Review of Cardiovascular Therapy 5:2, pages 135-138.
Read now
Read now
Articles from other publishers (45)
Martin Baroch, Hana Dejmková & Frank-Michael Matysik. (2023) Determination of trimetazidine in urine by capillary electrophoresis with amperometric detection. Monatshefte für Chemie - Chemical Monthly 154:9, pages 1013-1018.
Crossref
Crossref
Mohammad Hosein Farzaei, Fatemeh Ramezani-Aliakbari, Maryam Ramezani-Aliakbari, Mohammad Zarei, Alireza Komaki, Siamak Shahidi, Abdolrahman Sarihi & Iraj Salehi. (2023) Regulatory effects of trimetazidine in cardiac ischemia/reperfusion injury. Naunyn-Schmiedeberg's Archives of Pharmacology 396:8, pages 1633-1646.
Crossref
Crossref
Kamila Chomaničová, Élida Alechaga Silva & Rosa Ventura Alemany. (2023) Metabolic study of trimetazidine using ultra-high performance liquid chromatography-tandem mass spectrometry. Brazilian Journal of Pharmaceutical Sciences 59.
Crossref
Crossref
Susmita Patra, Pratibha Gupta, Reshma Kumari, Sandipan Jana, Pallab Kanti Haldar, Rudranil Bhowmik, Avishek Mandal, Md. Adil Shaharyar, Hindol Mazumdar, Kumar Anand & Sanmoy Karmakar. 2023. How Synthetic Drugs Work. How Synthetic Drugs Work
329
348
.
Houyong Zhu, Hanxin Wang, Xinyu Zhu, Qilan Chen, Xiaojiang Fang, Xiaoqun Xu, Yan Ping, Beibei Gao, Guoxin Tong, Yu Ding, Tielong Chen & Jinyu Huang. (2022) The Importance of Integrated Regulation Mechanism of Coronary Microvascular Function for Maintaining the Stability of Coronary Microcirculation: An Easily Overlooked Perspective. Advances in Therapy 40:1, pages 76-101.
Crossref
Crossref
Liana Kuprash, Olena Kuprash & Svetlana Gudarenko. (2022) Metabolic cardiocytoprotectors (trimetazidine and trimethylhydrazine) in geriatrics.
Short review. Ageing & Longevity:2 2022, pages 63-70.
Crossref
Crossref
Juan P. Ortiz Fragola, Gabriel Cao, Mariano Tumarkin, Marisa Moriondo, Angélica Muller, Martin Sangiorgio, Francisco Azzato, Giuseppe Ambrosio & José Milei. (2022) Bretschneider Solution and Two Antianginal Drugs Protect Peripheral Tissue in an Animal Model of Hemorrhagic Shock. Journal of Cardiovascular Pharmacology 79:6, pages 896-903.
Crossref
Crossref
Kirti Gupta, Sneha Pandey, Newly Bagang, Kamalpreet Mehra & Gaaminepreet Singh. (2021) Trimetazidine an emerging paradigm in renal therapeutics: Preclinical and clinical insights. European Journal of Pharmacology 913, pages 174624.
Crossref
Crossref
Elena Bobescu, Luigi Geo Marceanu, Lorena Dima, Andreea Balan, Christian Gabriel Strempel & Alexandru Covaciu. (2021) Trimetazidine Therapy in Coronary Artery Disease: The Impact on Oxidative Stress, Inflammation, Endothelial Dysfunction, and Long-Term Prognosis. American Journal of Therapeutics 28:5, pages e540-e547.
Crossref
Crossref
Kamila Raziyeva, Aiganym Smagulova, Yevgeniy Kim, Saltanat Smagul, Ayan Nurkesh & Arman Saparov. (2020) Preconditioned and Genetically Modified Stem Cells for Myocardial Infarction Treatment. International Journal of Molecular Sciences 21:19, pages 7301.
Crossref
Crossref
Manolis S. Kallistratos, Leonidas E. Poulimenos, Sofia Giannitsi, Pavlos Tsinivizov & Athanasios J. Manolis. (2018) Trimetazidine in the Prevention of Tissue Ischemic Conditions. Angiology 70:4, pages 291-298.
Crossref
Crossref
B. O. van Driel, A. C. van Rossum, M. Michels, R. Huurman & J. van der Velden. (2019) Extra energy for hearts with a genetic defect: ENERGY trial. Netherlands Heart Journal 27:4, pages 200-205.
Crossref
Crossref
Pravin G. Vanol, Manish Yadav, Mallika Sanyal, Priyanka A. Shah & Pranav S. Shrivastav. (2018) Overcoming interference of plasma phospholipids using HybridSPE for the determination of trimetazidine by UPLC-MS/MS. Biomedical Chromatography 32:2, pages e4095.
Crossref
Crossref
Giacinta Guarini, Alda Huqi, Doralisa Morrone, Paola Francesca Giuseppina Capozza & Mario Marzilli. (2018) Trimetazidine and Other Metabolic Modifiers. European Cardiology Review 13:2, pages 1.
Crossref
Crossref
D. I. Trukhan, A. L. Mazurov & E. L. Davydov. (2017) MYOCARDIAL CYTOPROTECTOR TRIMETAZIDINE MB-PREPARAT, INCREASES THE EFFECTIVENESS OF TREATMENT OF CHRONIC HEART FAILURE AND CORONARY HEART DISEASE. Medical Council:7, pages 75-83.
Crossref
Crossref
Arif Suner & Mustafa Cetin. (2016) The effect of trimetazidine on ventricular repolarization indexes and left ventricular diastolic function in patients with coronary slow flow. Coronary Artery Disease 27:5, pages 398-404.
Crossref
Crossref
Giacinta Guarini, Alda Huqi, Doralisa Morrone & Mario Marzilli. (2016) Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update. Cardiovascular Drugs and Therapy 30:4, pages 379-391.
Crossref
Crossref
Csaba A. Dézsi. (2016) Trimetazidine in Practice. American Journal of Therapeutics 23:3, pages e871-e879.
Crossref
Crossref
Hayam AteyyaHala YosefManar A. Nader. (2016) Ameliorative effect of trimetazidine on cisplatin-induced hepatotoxicity in rats. Canadian Journal of Physiology and Pharmacology 94:2, pages 225-230.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
279
284
.
Jinhong Wei, Hao Xu, Liang Shi, Jie Tong & Jianbao Zhang. (2015) Trimetazidine protects cardiomyocytes against hypoxia-induced injury through ameliorates calcium homeostasis. Chemico-Biological Interactions 236, pages 47-56.
Crossref
Crossref
D. I Trukhan. (2014) Therapeutic possibilities of myocardial cytoprotector trimetazidine MR incoronary heart disease. CardioSomatics 5:3-4, pages 41-47.
Crossref
Crossref
Anna Jarek, Marzena W?jtowicz, Dorota Kwiatkowska, Monika Kita, Ewa Turek-Lepa, Katarzyna Chajewska, Sylwia Lewandowska-Pachecka & Andrzej Pokrywka. (2014) The prevalence of trimetazidine use in athletes in Poland: excretion study after oral drug administration. Drug Testing and Analysis 6:11-12, pages 1191-1196.
Crossref
Crossref
Jianjun Zhang, Meng Fu, Minyan Zhang, Liang Xu & Yuan Gao. (2014) Synthesis of oxidized glycerol monooleate-chitosan polymer and its hydrogel formation for sustained release of trimetazidine hydrochloride. International Journal of Pharmaceutics 465:1-2, pages 32-41.
Crossref
Crossref
Giacinta Guarini, Alda Huqi & Mario Marzilli. 2014. Cardiac Energy Metabolism in Health and Disease. Cardiac Energy Metabolism in Health and Disease
237
248
.
Gulistan Beshimovna Dorofeeva, Ivan Vasil'evich Dorofeev, Yuliya Viktorovna Trofimova & Ol'ga Vladimirovna Manerova. (2013) Rol' trimetazidina v regulyatsii energeticheskogo metabolizma miokarda pri serdechno-sosudistykh zabolevaniyakh. Systemic Hypertension 10:3, pages 92-97.
Crossref
Crossref
De la Cruz Rodríguez Lilia Cristina, Rey María del Rosario, Araujo Carmen Rosa & Oldano Ana Veronica. (2013) On the Performance of Trimetazidine and Vitamin E as Pharmacoprotection Agents in Cyclosporin A-Induced Toxicity. ISRN Pharmacology 2013, pages 1-9.
Crossref
Crossref
H P Rang, M M Dale, J M Ritter, R J Flower & G Henderson. 2012. Rang & Dale's Pharmacology. Rang & Dale's Pharmacology
246
264
.
Vladimír Teplan. (2011) Use of trimetazidine in preventing contrast-induced nephropathy: a nephrologist's perspective. Cor et Vasa 53:4-5, pages 264-266.
Crossref
Crossref
Lilia Cristina De la Cruz Rodríguez, Carmen Rosa Araujo, Sara Emilia Posleman & María Rosario Rey. (2010)
Attenuation of gentamicin‐induced nephrotoxicity: trimetazidine versus
N
‐acetyl cysteine
. Journal of Applied Toxicology 30:4, pages 343-353.
Crossref
Crossref
Yilmaz Gunes, Unal Guntekin, Mustafa Tuncer & Musa Sahin. (2009) Improved left and right ventricular functions with trimetazidine in patients with heart failure: a tissue Doppler study. Heart and Vessels 24:4, pages 277-282.
Crossref
Crossref
Gitte Meriläinen, Werner Schmitz, Rik K. Wierenga & Petri Kursula. (2008) The sulfur atoms of the substrate CoA and the catalytic cysteine are required for a productive mode of substrate binding in bacterial biosynthetic thiolase, a thioester‐dependent enzyme. The FEBS Journal 275:24, pages 6136-6148.
Crossref
Crossref
Christophe Jayle, Frederic Favreau, Kequiang Zhang, Carole Doucet, Jean Michel Goujon, William Hebrard, Michel Carretier, Michel Eugene, Gerard Mauco, Jean Paul Tillement & Thierry Hauet. (2007) Comparison of protective effects of trimetazidine against experimental warm ischemia of different durations: early and long-term effects in a pig kidney model. American Journal of Physiology-Renal Physiology 292:3, pages F1082-F1093.
Crossref
Crossref
Alexandra Labrou, George Giannoglou, Dimitrios Zioutas, Nikolaos Fragakis, George Katsaris & George Louridas. (2007) Trimetazidine Administration Minimizes Myocardial Damage and Improves Left Ventricular Function after Percutaneous Coronary Intervention. American Journal of Cardiovascular Drugs 7:2, pages 143-150.
Crossref
Crossref
HP Rang, MM Dale, JM Ritter & RJ Flower. 2007. Rang & Dale's Pharmacology. Rang & Dale's Pharmacology
277
297
.
Ger J. van der Vusse & Marc van Bilsen. (2016) Free Fatty Acids and Postischemic Myocardial Function. Seminars in Cardiothoracic and Vascular Anesthesia 10:3, pages 231-235.
Crossref
Crossref
Dan Meng, Lin Feng, Xiang-Jian Chen, Di Yang & Ji-Nan Zhang. (2006)
Trimetazidine improved Ca
2+
handling in isoprenalinemediated myocardial injury of rats
. Experimental Physiology 91:3, pages 591-601.
Crossref
Crossref
Ergun Topal, Ramazan Ozdemir, Irfan Barutcu, Yüksel Aksoy, Isa Sincer, Erdal Akturk & Sengül Çehreli. (2006) The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow. Journal of Electrocardiology 39:2, pages 211-218.
Crossref
Crossref
Evaristo Castedo, Javier Segovia, Cristina Escudero, Begoña Olmedilla, Fernando Granado, Carmen Blas, José M. Guardiola, Isabel Millán, Luis A. Pulpón & Juan Ugarte. (2005) Daño por isquemia-reperfusión durante el trasplante cardíaco experimental. Evaluación del papel citoprotector de la trimetazidina. Revista Española de Cardiología 58:8, pages 941-950.
Crossref
Crossref
Marisol Ruiz-Meana. (2005) Trimetazidina, estr?s oxidativo y da?o celular durante la reperfusi?n mioc?rdica. Revista Espa?ola de Cardiolog?a 58:8, pages 895-897.
Crossref
Crossref
Evaristo Castedo, Javier Segovia, Cristina Escudero, Begoña Olmedilla, Fernando Granado, Carmen Blas, José M. Guardiola, Isabel Millán, Luis A. Pulpón & Juan Ugarte. (2005) Ischemia-Reperfusion Injury During Experimental Heart Transplantation. Evaluation of Trimetazidine's Cytoprotective Effect. Revista Española de Cardiología (English Edition) 58:8, pages 941-950.
Crossref
Crossref
Marisol Ruiz-Meana. (2005) Trimetazidine, Oxidative Stress, and Cell Injury During Myocardial Reperfusion. Revista Espa?ola de Cardiolog?a (English Edition) 58:8, pages 895-897.
Crossref
Crossref
Isabella Tritto, Penghai Wang, Periannan Kuppusamy, Roberto Giraldez, Jay L Zweier & Giuseppe Ambrosio. (2005) The Anti-Anginal Drug Trimetazidine Reduces Neutrophil-Mediated Cardiac Reperfusion Injury. Journal of Cardiovascular Pharmacology 46:1, pages 89-98.
Crossref
Crossref
C. Pantos, A. Bescond-Jacquet, S. Tzeis, I. Paizis, I. Mourouzis, P. Moraitis, V. Malliopoulou, E. D. Politi, H. Karageorgiou, D. Varonos & D. V. Cokkinos. (2004) Trimetazidine protects isolated rat hearts against ischemia?reperfusion injury in an experimental timing ? dependent manner. Basic Research in Cardiology 100:2, pages 154-160.
Crossref
Crossref
Taher El-Kady, Khaled El-Sabban, Mohamed Gabaly, Ahmed Sabry & Sherif Abdel-Hady. (2005) Effects of Trimetazidine on Myocardial Perfusion and the Contractile Response of Chronically Dysfunctional Myocardium in Ischemic Cardiomyopathy. American Journal of Cardiovascular Drugs 5:4, pages 271-278.
Crossref
Crossref